CARM1 and non-small cell lung carcinoma: As shown in Figure 4A, we observed that the enrichment of H3R17me2a and H3R26me2a (catalyzed by CARM1) at the promoter region of CCNE2 gene was dramatically reduced when NSCLC PC9 and HCC827 cells were treated with EZM2302.